Marimed (MRMD) Receivables - Net (2011 - 2026)

Marimed (MRMD) has 15 years of Receivables - Net data on file, last reported at $9.4 million in Q1 2026.

• On a quarterly basis, Receivables - Net rose 2.8% year-over-year to $9.4 million in Q1 2026; TTM through Mar 2026 was $9.4 million, a 2.8% increase from a year earlier, with the FY2025 full-year figure at $9.4 million, up 4.49% from the prior year.
• Receivables - Net for Q1 2026 stood at $9.4 million, up from $9.1 million in the prior quarter.
• Over the last five years, Receivables - Net for MRMD reached as high as $9.4 million in Q1 2026 and fell as low as $3.5 million in Q1 2022.
• Historically, Receivables - Net has averaged $7.1 million across 5 years, with a median of $7.3 million in 2024.
• On a YoY basis, Receivables - Net climbed as much as 425.81% in 2022 and fell as far as 52.84% in 2022.
• Year by year, Receivables - Net stood at $8.8 million in 2022, then fell by 17.82% to $7.2 million in 2023, then grew by 21.43% to $8.7 million in 2024, then advanced by 4.26% to $9.1 million in 2025, then climbed by 3.57% to $9.4 million in 2026.
• Per Business Quant data, the three most recent Receivables - Net figures were $9.4 million in Q1 2026, $9.1 million in Q4 2025, and $8.0 million in Q3 2025.